**Core Concept**
Myocardial infarction (MI) triggers a complex series of cellular and molecular events, leading to tissue damage and necrosis. The early phase of MI involves the activation of various cellular pathways, including inflammation, apoptosis, and necrosis.

**Why the Correct Answer is Right**
In the early phase of myocardial infarction, the myocardial tissue undergoes ischemic injury, leading to the activation of lysosomes, which release proteolytic enzymes and cause cellular damage. This process is accompanied by the release of inflammatory mediators, such as bradykinin, histamine, and serotonin, which contribute to the development of edema and tissue damage. **Option C: Coagulative necrosis** is indeed seen in the early phase of myocardial infarction, as it is a hallmark of ischemic injury.

**Why Each Wrong Option is Incorrect**
* **Option A:** Acute inflammatory response is seen in the early phase of myocardial infarction, characterized by the infiltration of neutrophils and macrophages, leading to the release of pro-inflammatory cytokines and chemokines. This response contributes to tissue damage and the development of edema.
* **Option B:** Apoptosis, or programmed cell death, is also observed in the early phase of myocardial infarction, particularly in the border zones of the infarcted area. This process is mediated by various cellular pathways, including the activation of caspases and the release of pro-apoptotic factors.
* **Option D:** While fibrosis is a characteristic feature of chronic myocardial infarction, it is not typically seen in the early phase of MI. However, the deposition of fibrin and the activation of fibroblasts can occur in the early stages, laying the groundwork for the development of fibrosis in the later stages of healing.

**Clinical Pearl / High-Yield Fact**
The early phase of myocardial infarction is characterized by a complex interplay of cellular and molecular events, including inflammation, apoptosis, and necrosis. Understanding these mechanisms is crucial for the development of effective therapeutic strategies to minimize tissue damage and improve patient outcomes.

**Correct Answer: C. Coagulative necrosis**